本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688269 证券简称：凯立新材 公告编号：2024-046 西安凯立新材料股份有限公司 2024 年第三次临时股东大会决议公告 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2024 年 12 月 2 日 （二） 股东大会召开的地点：西安经济技术开发区高铁新城尚林路 4288 号凯立 新材综合办公楼 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： （四） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 115 | | --- | --- | | 普通股股东人数 | 115 | | 2、出席会议的股东所持有的表决权数量 | 55,546,726 | | 普通股股东所持有表决权数量 | 55,546,726 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 42.498 ...

国浩律师(西安)事务所 关于西安凯立新材料股份有限公司 2024 年第三次临时股东大会的 法律意见书 致:西安凯立新材料股份有限公司 根据《中华人民共和国证券法》(以下简称"《证券法》")、《中华人民 共和国公司法》〈以下简称"《公司法》"）及中国证券监督管理委员会《上市 公司股东大会规则》(2022年修订)(以下简称"《股东大会规则》"))等法 律、行政法规和规范性文件的规定,国浩律师(西安)事务所(以下简称"本所" 或"国浩")接受西安凯立新材料股份有限公司(以下简称"公司"或"凯立新 材")的委托,指派律师出席公司 2024年第三次临时股东大会(以下简称"本 次股东大会"）,并对本次股东大会的相关事项进行见证,依法出具本法律意见 书。 国浩及经办律师依据《证券法》《律师事务所从事证券法律业务管理办法》 和《律师事务所证券法律业务执业规则(试行)》等规定及本法律意见书出具日 以前已经发生或存在的事实,严格履行了法定职责,遵循了勤勉尽责和诚实信用 原则,进行了充分的核查验证,保证本法律意见书所认定的事实真实、准确、完 整,所发表的结论性意见合法、准确,不存在虚假记载、误导性陈述或者重大遗 漏,并承担相应法律 ...

西安凯立新材料股份有限公司 2024 年第三次临时股东大会 证券代码：688269 证券简称：凯立新材 西安凯立新材料股份有限公司 2024 年第三次临时股东大会会议资料 二〇二四年十二月 中国西安 1 西安凯立新材料股份有限公司 2024 年第三次临时股东大会 目录 | 目录 2 | | --- | | 西安凯立新材料股份有限公司 3 | | 2024 年第三次临时股东大会会议须知 3 | | 西安凯立新材料股份有限公司 5 | | 2024 年第三次临时股东大会会议议程 5 | | 议案一 7 | | 关于公司 2024 年第三季度利润分配方案的议案 7 | 2 一、为确认出席大会的股东或其代理人或其他出席者的出席资格，会议工作 人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。出席会 议的股东及股东代理人须在会议召开前 30 分钟到会议现场办理签到手续，并请 按规定出示证券账户卡、身份证明文件或法人单位证明、授权委托书等，经验证 后方可出席会议。 二、为保证本次大会的严肃性和正常秩序，切实维护与会股东（或股东代理 人）的合法权益，务请出席大会的股东或其代理人或其他出席者准时到达会场签 到确 ...

Investment Rating - The report maintains a "Buy" rating for the company, with a target price indicating an expected return of over 20% within the next six months [6][14]. Core Views - The company reported a revenue decline of 14.7% year-on-year for the first three quarters of 2024, totaling 1.143 billion yuan, while the net profit attributable to shareholders decreased by 34.5% to 64.04 million yuan [1]. - The third quarter saw a revenue of 331 million yuan, down 10.7% year-on-year and 34.84% quarter-on-quarter, but net profit increased by 163.1% year-on-year to 17.26 million yuan [1]. - The decline in revenue is attributed to the falling prices of precious metals, particularly palladium, which saw a significant year-on-year drop of 23.12% [3]. - The company is investing in a hydrogenated nitrile butadiene rubber (HNBR) project, with a total planned investment of 350 million yuan, aiming to enhance its competitiveness in high-end materials [4]. Financial Summary - The company's revenue for 2024 is projected to be 1.733 billion yuan, reflecting a decrease of 2.93% compared to 2023, with a recovery expected in subsequent years [5][10]. - The net profit forecast for 2024 is adjusted to 110.49 million yuan, down from previous estimates due to changes in precious metal prices [4][9]. - The gross margin for Q3 2024 improved to 13.62%, up 5.24 percentage points year-on-year, indicating a recovery in profitability despite revenue declines [2]. Business Operations - The company operates in three business models: sales, processing, and technical services, which have varying gross margin levels, impacting overall revenue and profitability [2]. - The increase in expenses, particularly in financial and sales costs, contributed to the overall profit decline, with total expenses rising by 422,000 yuan year-on-year in Q3 [1]. Market Context - The precious metals market, particularly palladium, is currently in a down cycle, which has adversely affected the company's revenue [3]. - The investment in the HNBR project is seen as a strategic move to diversify and strengthen the company's position in the high-end materials sector [4].

Group 1: Hydrogen Energy Projects - The company is involved in hydrogen energy projects related to hydrogen production, storage, and applications, with ongoing research projects in PEM electrolysis catalysts and proton exchange membrane fuel cell catalysts currently in trial production and promotion stages [2] - New organic liquid hydrogen storage systems are in the mid-stage optimization phase of development and industrialization [2] Group 2: Revenue Distribution - In the first three quarters of 2024, the main business revenue distribution is as follows: pharmaceutical sector 42.04%, basic chemicals 22.12%, and new chemical materials 21.82% [2] Group 3: Catalyst Development - The high-performance alkane dehydrogenation platinum-based catalyst project is in the batch production and production line construction debugging phase [2] - For the PVC mercury-free catalyst, 245 tons were sold from January to September 2024, representing a 68.38% increase compared to the same period last year, with 154.89 tons of unexecuted orders signed as of September 30, 2024 [2] Group 4: Raw Material Price Impact - Fluctuations in precious metal prices may affect customer procurement rhythms but will not impact catalyst demand volume; inventory levels have increased primarily due to higher raw material and turnover material quantities compared to the beginning of the year [3]

Financial Performance - The company's operating revenue for Q3 2024 was ¥330,731,831.98, a decrease of 10.69% compared to the same period last year[2]. - Net profit attributable to shareholders for Q3 2024 was ¥17,264,671.77, an increase of 163.11% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was ¥15,467,028.14, up 174.24% year-on-year[2]. - The net profit attributable to shareholders for the year-to-date period decreased by 34.45% due to declining revenue and rising costs[5]. - Total operating revenue for the first three quarters of 2024 was CNY 1,143,179,877.40, a decrease of 14.7% compared to CNY 1,339,914,386.76 in the same period of 2023[11]. - Net profit for the first three quarters of 2024 was CNY 63,993,284.11, a decline of 34.5% from CNY 97,697,786.01 in the same period of 2023[14]. - The company's total liabilities increased to CNY 825,804,403.77 in Q3 2024, up from CNY 538,058,061.81 in Q3 2023, representing a growth of 53.5%[11]. - The total equity attributable to shareholders of the parent company was CNY 987,132,208.52, slightly down from CNY 988,427,154.75 in the previous year[11]. Cash Flow - The net cash flow from operating activities for Q3 2024 was -¥67,083,199.43, a decrease of 4402.39% compared to the previous year[3]. - The net cash flow from operating activities for the first three quarters of 2024 was -CNY 31,892,407.79, a decrease from CNY 46,999,651.29 in the previous year[15]. - The cash inflow from operating activities generated a net amount of CNY 68,707,148.48 in the first three quarters of 2024, compared to a negative cash flow of CNY -28,440,905.80 in the same period of 2023[21]. - The total cash outflow from investment activities was CNY 305,404,979.02, significantly higher than CNY 158,804,778.10 in the same period last year, resulting in a net cash flow from investment activities of -CNY 235,128,926.29[16]. - Cash inflow from financing activities reached CNY 427,600,000.00, compared to CNY 150,000,000.00 in the previous year, indicating a substantial increase[16]. - The net cash flow from financing activities was CNY 183,274,922.01, a recovery from -CNY 149,342,304.17 in the same period last year[16]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,842,889,119.55, an increase of 20.25% compared to the end of the previous year[3]. - As of September 30, 2024, total assets reached approximately CNY 1.84 billion, an increase from CNY 1.53 billion at the end of 2023, reflecting a growth of about 20.25%[9]. - Current assets totaled CNY 871.84 million, up from CNY 791.07 million, indicating an increase of approximately 10.19%[9]. - The company's total assets reached CNY 1,612,266,988.71 in Q3 2024, up from CNY 1,336,719,385.01 in Q3 2023, marking an increase of about 20.5%[20]. - The company's total liabilities increased to CNY 636,555,947.20 in Q3 2024 from CNY 367,954,681.14 in Q3 2023, indicating a significant rise of about 73%[20]. Research and Development - Research and development expenses totaled ¥11,562,357.94, a decrease of 8.42% year-on-year, accounting for 3.50% of operating revenue[3]. - Research and development expenses for the first three quarters of 2024 were CNY 33,682,861.67, a decrease from CNY 37,507,682.06 in the same period of 2023[13]. - The company's financial expenses increased to CNY 4,246,919.31 in the first three quarters of 2024, compared to CNY 2,007,294.65 in the same period of 2023, representing an increase of approximately 111.5%[19]. Sales and Inventory - The company experienced a 210.28% increase in catalyst sales volume compared to the same quarter last year, contributing to the profit growth[5]. - Accounts receivable rose significantly to CNY 218.27 million, compared to CNY 113.30 million, marking an increase of approximately 92.73%[9]. - Inventory increased to CNY 239.93 million from CNY 196.09 million, representing a growth of about 22.36%[9]. - The company's inventory as of September 30, 2024, was CNY 194,315,227.57, up from CNY 182,385,028.72 in the same period last year[17]. Other Financial Metrics - The basic earnings per share for Q3 2024 was ¥0.13, a decrease of 34.67% compared to the same period last year[3]. - Earnings per share for the first three quarters of 2024 were CNY 0.49, compared to CNY 0.75 in the same period of 2023, indicating a decrease of 34.7%[14]. - The company reported a net profit margin of approximately 5.6% for the first three quarters of 2024, down from 7.3% in the same period of 2023[14]. - The company reported a significant increase in contract liabilities to CNY 49.73 million from CNY 7.52 million, a rise of about 563.00%[10]. Strategic Developments - The company has not disclosed any new product developments or market expansion strategies in the current report[8]. - The company is set to adopt new accounting standards starting in 2024, which may impact future financial reporting[23].

证券代码：688269 证券简称：凯立新材 公告编号：2024-043 西安凯立新材料股份有限公司 第四届监事会第二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 公司《2024 年第三季度报告》的编制和审议程序符合相关法律法规及《公司 章程》等相关规定，公允地反映了公司 2024 年第三季度的财务状况和经营成果； 在编制过程中，未发现公司参与年度报告编制和审议的人员有违反保密规定的行 为；公司《2024 年第三季度报告》披露的信息真实、准确、完整，不存在任何虚 假记载、误导性陈述或者重大遗漏。具体内容详见公司 2024 年 10 月 29 日刊载于 上海证券交易所网站（www.sse.com.cn）的《2024 年第三季度报告》（公告编号： 2024-042）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 2、审议通过《关于公司 2024 年第三季度利润分配方案的议案》 公司监事会同意公司以实施权益分派股权登记日登记的总股本为基数，向全 体股东每 10 股派发现金红利 2 元（含税），以总股本 ...

证券代码：688269 证券简称：凯立新材 公告编号：2024-045 西安凯立新材料股份有限公司 关于召开 2024 年第三次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024 年第三次临时股东大会 召开日期时间：2024 年 12 月 2 日 15 点 30 分 股东大会召开日期：2024年12月2日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 召开地点：西安经济技术开发区高铁新城尚林路 4288 号凯立新材综合办公 楼 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2024 年 12 月 2 日 至 2024 年 12 月 2 日 采用上海证券交易所网络投票系统，通过交易系统投 ...

证券代码：688269 证券简称：凯立新材 公告编号：2024-044 西安凯立新材料股份有限公司 2024 年第三季度利润分配方案公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、利润分配方案内容 根据西安凯立新材料股份有限公司（以下简称"公司"） 2024 年第三季度报 告（未经审计），截至 2024 年 9 月 30 日，公司母公司财务报表可供分配利润为人 民币 33,200.55 万元。经董事会决议，公司拟以实施权益分派股权登记日登记的总 股本为基数分配利润。本次利润分配方案如下： （一）公司拟向全体股东每 10 股派发现金红利人民币 2.00 元（含税），不送 红股，不以资本公积转增股本。截至 2024 年 9 月 30 日，公司总股本 13,070.4 万 股，以此计算拟派发现金红利人民币 2,614.08 万元（含税）。 （二）如在本公告披露之日起至实施权益分派股权登记日期间，公司总股本 发生变动的，拟维持每股分配比例不变，相应调整分配总额，并在相关公告中披露。 1 每股分配比例：每 ...

西安凯立新材料股份有限公司 并同意将此议案提交董事会审议。 (以下无正文) 西安凯立新材料股份有限公司 西安凯立新材料股份有限公司 独立董事专门会议 2024年第五次会议决议 西安凯立新材料股份有限公司(以下简称"公司")独立董事专门会议 2024 年第五次会议于 2024年 10月 28 日(星期一)在西安经济技术开发区高铁新城 尚林路 4288 号凯立新材综合楼办公室以现场结合通讯的方式召开。会议通知已 于 2024 年 10 月 25 日通过邮件的方式送达各位独立董事。本次会议应出席独立 董事 3人,实际出席独立董事 3人。 会议由独立董事张宁生主持。会议召开符合有关法律、法规、规章和《公 司章程》的规定。经各位独立董事认真审议,会议形成了如下决议: 一、审议通过《关于公司 2024年第三季度利润分配方案的议案》 表决结果:3 票同意,0 票反对,0 票弃权。 2024年10月28日 独立董事专门会议 ...